Lantheus Holdings, Inc
$100.80
$0.26 (+0.26%)
$100.64Day Range$101.05
Key Statistics
Market Cap
$6.57B
Shares Outstanding
65.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 25, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$100.91
Day High
$101.05
Day Low
$100.64
Volume
612.1K
VWAP
$100.86
Prev Close
$100.54
Transactions
--
Acc. Volume
--
About Lantheus Holdings, Inc
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESSIC 28351,193 employees331 TREBLE COVE ROAD, NORTH BILLERICA, MA, 01862978 671-8001IPO Jun 25, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001521036
- Composite FIGI
- BBG006Q52RD0
- Share Class FIGI
- BBG006Q52RF8
- Ticker Root
- LNTH
- SIC Code
- 2835
About Lantheus Holdings, Inc (LNTH) Stock
Lantheus Holdings, Inc (LNTH) closed the 2026-09-17 session at $100.80, up 0.26% versus the previous close (+0.26). The stock opened at $100.91 and traded between $100.64 and $101.05 during that session. Session trading volume was 612K shares. The volume-weighted average price (VWAP) is $100.86.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Lantheus Holdings, Inc has a market capitalization of $6.57 billion. The company operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry classification. LNTH is listed on the XNAS exchange. The company employs approximately 1,193 people. Lantheus Holdings, Inc is headquartered in NORTH BILLERICA, MA. The recorded listing date is 2015-06-25.
On this page you can find market LNTH stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.